Guidance for carmine labeling
This article was originally published in The Rose Sheet
Executive Summary
FDA offers guidance for small businesses on declaring and labeling cochineal extract and carmine in food and cosmetic products. Published in the April 30 Federal Register, the small entity compliance guide describes "in plain language" the requirements of a final rule issued in January, under which companies must declare the presence of carmine and cochineal extract in labeling for foods and cosmetic products that contain them. Rule goes into effect Jan. 5, 2011. Carmine and cochineal extract are bright-red pigments used in makeup and nail polish, among other products; both are derived from insects. Action is being taken to alert consumers who are allergic to the substances or otherwise want to avoid them (1"The Rose Sheet" Jan. 12, 2009, p. 6)
You may also be interested in...
Cosmetics Must Disclose Use Of Color Additive Carmine In Labeling – FDA Rule
Cosmetic manufacturers have two years to implement labeling changes alerting consumers to the use of the color additive carmine under a final rule announced by FDA in the Federal Register Jan. 5
There’s ‘No Silver Bullet’ For Making Medicines Packaging Sustainable
There’s no simple answer to the question of how to make medicines packaging sustainable, says international recycling consultancy and Veolia Group subsidiary Circpack. “Manufacturers need to assess what works best for them, and recyclers will do the same,” Circpack analyst and circular packaging expert Filipe Vieira de Castro tells HBW Insight in this exclusive Q&A. “The best thing we can all do is put effort into finding common ground between systems, which comes down to better understanding the complexities between them.”
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.